Evidence map›Paper›PMID 36982491›Full record

ArticleInternational journal of molecular sciences2023

Heterologous Expression and Bioactivity Determination of

Xu Chu, Di Jiang, Lu Yu, Ming Li, Songqing Wu, Feiping Zhang, Xia Hu

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Optimization and Stability Assessment ofInternational journal of molecular sciences · 2024
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xu ChuForestry College, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Di JiangForestry College, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Lu YuForestry College, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Ming LiForestry College, Fujian Agriculture and Forestry University, Fuzhou 350002, China.ORCID 0000-0003-4006-575X
Songqing WuForestry College, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Feiping ZhangForestry College, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Xia HuForestry College, Fujian Agriculture and Forestry University, Fuzhou 350002, China.
Fujian Agriculture and Forestry University · CN

Funding

Forestry Key Program of Science and Technology in Fujian Province 2021FKJ03Forestry Peak Discipline Construction Project of Fujian Agriculture and Forestry University 72202200205National Key R & D Program of China 2021YFD1400900National Natural Science Foundation of China 31800548Natural Science Foundation of Fujian Province, China 2021J01056Science and Technology innovation Special Fund project of Fujian Agriculture and Forestry University KFb22037XAthe National Major Emergency Science and Technology Program of China ZD202001
6 · The paper itself

Abstract

Insects have evolved to form a variety of complex natural compounds to prevent pathogen infection in the process of a long-term attack and defense game with various pathogens in nature. Antimicrobial Peptides (AMPs) are important effector molecules of the insect immune response to the pathogen invasion involved in bacteria, fungi, viruses and nematodes. The discovery and creation of new nematicides from these natural compounds is a key path to pest control. A total of 11 AMPs from

Indexed as

ColeopteraRhabditidaAnimalsAntinematodal AgentsInsectaPeptidesSaccharomycetalesAntinematodal AgentsPeptidesantimicrobial peptidebioactivityheterologous expressionMonochamus alternatus

Identifiers

PMID36982491
PMCPMC10049621
OpenAlexW4324057543

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read56
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.